You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.

ZYME Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.63%

Insider Buying (Last 12 Months): $16,073,510.00

Insider Selling (Last 12 Months): $45,873.89

Zymeworks Insider Trading History Chart

Zymeworks Share Price & Price History

^$9.58

▼ -0.17 (-1.74%)

As of 01/27/2023 01:00 AM ET

Days: 30 | 90 | 365

The Next Big Crisis Is Here

From Porter & Company | Ad

You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.

Click here to watch it, free.

Zymeworks Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2023	Ecor1 Capital, Llc	Major Shareholder	Buy	144,100	$9.49	$1,367,509.00	9,724,073
1/17/2023	Ecor1 Capital, Llc	Major Shareholder	Buy	440,000	$9.80	$4,312,000.00	9,376,973
1/13/2023	Ecor1 Capital, Llc	Major Shareholder	Buy	342,100	$9.81	$3,356,001.00	8,936,973
1/10/2023	Ecor1 Capital, Llc	Major Shareholder	Buy	920,000	$7.65	$7,038,000.00	8,488,573
12/12/2022	Christopher Astle	CFO	Sell	887	$6.01	$5,330.87	1,333
11/10/2022	Neil Josephson	Insider	Sell	2,475	$8.10	$20,047.50	14,449
3/10/2022	Neil A. Klompas	COO	Sell	2,979	$6.88	$20,495.52
1/7/2022	Neil Josephson	Insider	Buy	5,000	$14.28	$71,400.00
7/15/2021	Ali Tehrani	CEO	Sell	3,800	$36.00	$136,800.00	264,125
7/12/2021	Ali Tehrani	CEO	Sell	12,669	$36.12	$457,604.28	272,994
4/13/2021	James Priour	Insider	Sell	950	$27.93	$26,533.50	2,953
3/15/2021	Kathryn O'Driscoll	Insider	Sell	786	$34.72	$27,289.92	5,003
3/10/2021	Ali Tehrani	CEO	Sell	4,392	$34.95	$153,500.40	264,717
3/10/2021	Kathryn O'Driscoll	Insider	Sell	568	$34.95	$19,851.60	6,357
3/10/2021	Neil A. Klompas	CFO	Sell	1,425	$34.95	$49,803.75	11,896
12/9/2020	Neil A. Klompas	CFO	Sell	25,000	$53.25	$1,331,250.00	17,502
12/7/2020	Ali Tehrani	CEO	Sell	850	$56.16	$47,736.00	257,009
12/4/2020	Diana Hausman	Insider	Sell	6,032	$55.12	$332,483.84	6,568
12/2/2020	Diana Hausman	Insider	Sell	701	$55.01	$38,562.01	7,840
11/2/2020	Ali Tehrani	CEO	Sell	3,500	$39.04	$136,640.00	257,009
9/14/2020	Diana Hausman	Insider	Sell	40,000	$45.00	$1,800,000.00	13,718
4/3/2020	Ali Tehrani	CEO	Buy	575	$33.39	$19,199.25	256,009

Is This The End of Capitalism?

From Porter & Company | Ad

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

click here now to get all the chilling details.

SEC Filings (Institutional Ownership Changes) for Zymeworks (NYSE:ZYME)

88.28% of Zymeworks stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Zymeworks Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/25/2023	Stephens Inc. AR	56,647	$0.45M	0.0%	N/A	0.090%
1/23/2023	Allspring Global Investments Holdings LLC	38,299	$0.30M	0.0%	-12.8%	0.061%
11/16/2022	Jane Street Group LLC	36,572	$0.23M	0.0%	-48.7%	0.058%
11/15/2022	State Street Corp	99,363	$0.61M	0.0%	+92.6%	0.158%
11/15/2022	Thrivent Financial for Lutherans	16,082	$93K	0.0%	N/A	0.026%
11/15/2022	Trexquant Investment LP	93,824	$0.58M	0.0%	+70.2%	0.149%
11/15/2022	Vanguard Group Inc.	523,983	$3.22M	0.0%	-13.6%	0.832%
11/15/2022	Perceptive Advisors LLC	4,400,099	$27.06M	0.8%	+6.5%	6.985%
11/15/2022	Platinum Investment Management Ltd.	373,992	$2.30M	0.1%	+26.6%	0.594%
11/15/2022	Quinn Opportunity Partners LLC	456,822	$2.81M	0.3%	-71.3%	0.725%
11/15/2022	Bayesian Capital Management LP	23,768	$0.15M	0.0%	-56.3%	0.038%
11/15/2022	BlackRock Inc.	581,709	$3.58M	0.0%	-0.5%	0.923%
11/15/2022	CI Investments Inc.	146,470	$0.90M	0.0%	-57.4%	0.232%
11/14/2022	Armistice Capital LLC	5,785,000	$35.58M	0.6%	+0.2%	9.183%
11/14/2022	Royal Bank of Canada	33,882	$0.21M	0.0%	N/A	0.054%
11/14/2022	Point72 Asset Management L.P.	244,000	$1.50M	0.0%	N/A	0.387%
11/14/2022	Cubist Systematic Strategies LLC	8,524	$52K	0.0%	-96.3%	0.014%
11/14/2022	Renaissance Technologies LLC	57,777	$0.36M	0.0%	N/A	0.092%
11/14/2022	Ergoteles LLC	59,457	$0.37M	0.0%	N/A	0.094%
11/14/2022	UBS Oconnor LLC	215,000	$1.32M	0.0%	+124.0%	0.341%
11/10/2022	Credit Suisse AG	2,440,372	$15.01M	0.0%	-0.1%	4.049%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	24,583	$0.15M	0.0%	+50.9%	0.041%
11/10/2022	ExodusPoint Capital Management LP	11,079	$68K	0.0%	N/A	0.018%
11/10/2022	Strategic Wealth Advisors Group LLC	296,375	$1.82M	0.1%	N/A	0.492%
11/10/2022	Timelo Investment Management Inc.	404,226	$2.49M	2.9%	-56.4%	0.671%
11/9/2022	Picton Mahoney Asset Management	104,405	$0.64M	0.0%	-11.9%	0.173%
11/4/2022	Russell Investments Group Ltd.	53,755	$0.33M	0.0%	-64.1%	0.089%
10/26/2022	Allspring Global Investments Holdings LLC	43,927	$0.27M	0.0%	+95.1%	0.073%
10/25/2022	Janney Montgomery Scott LLC	52,376	$0.32M	0.0%	+410.1%	0.087%
10/25/2022	Raymond James & Associates	165,933	$1.02M	0.0%	+2.7%	0.275%
10/25/2022	Raymond James Financial Services Advisors Inc.	72,524	$0.45M	0.0%	+3.2%	0.120%
10/18/2022	Firethorn Wealth Partners LLC	11,800	$73K	0.1%	-42.7%	0.020%
10/13/2022	National Bank of Canada FI	395,478	$2.43M	0.0%	+24.1%	0.683%
8/24/2022	Prelude Capital Management LLC	18,570	$98K	0.0%	+58.7%	0.032%
8/19/2022	Walleye Capital LLC	204,096	$1.08M	0.0%	-26.1%	0.353%
8/18/2022	Goldman Sachs Group Inc.	1,179,893	$6.25M	0.0%	+126.7%	2.038%
8/17/2022	Parallax Volatility Advisers L.P.	30,000	$0.16M	0.0%	N/A	0.052%
8/16/2022	First Republic Investment Management Inc.	15,000	$80K	0.0%	+50.0%	0.026%
8/16/2022	Jane Street Group LLC	71,264	$0.38M	0.0%	+199.2%	0.123%
8/16/2022	Woodline Partners LP	1,641,876	$8.70M	0.1%	-25.9%	2.836%
8/16/2022	Pura Vida Investments LLC	44,696	$0.24M	0.0%	N/A	0.077%
8/15/2022	State Street Corp	51,578	$0.27M	0.0%	-62.4%	0.089%
8/15/2022	Parallax Volatility Advisers L.P.	30,000	$0.16M	0.0%	N/A	0.052%
8/15/2022	Clearline Capital LP	193,288	$1.02M	0.1%	N/A	0.334%
8/15/2022	Cubist Systematic Strategies LLC	229,790	$1.22M	0.0%	+1,380.6%	0.397%
8/13/2022	Quantbot Technologies LP	10,300	$54K	0.0%	+58.9%	0.018%
8/13/2022	Virtu Financial LLC	13,269	$70K	0.0%	N/A	0.023%
8/12/2022	Northern Trust Corp	12,115	$64K	0.0%	-73.5%	0.021%
8/12/2022	Virtus ETF Advisers LLC	17,848	$95K	0.0%	+83.1%	0.031%
8/12/2022	Ensign Peak Advisors Inc	15,620	$83K	0.0%	+88.9%	0.027%
8/12/2022	Credit Suisse AG	2,442,997	$12.95M	0.0%	-1.3%	4.220%
8/12/2022	CI Investments Inc.	344,150	$1.82M	0.0%	+116.4%	0.594%
8/11/2022	Trexquant Investment LP	55,110	$0.29M	0.0%	N/A	0.095%
8/11/2022	Bank of Montreal Can	33,766	$0.19M	0.0%	+35.8%	0.058%
8/11/2022	Platinum Investment Management Ltd.	295,486	$1.57M	0.1%	+25.6%	0.510%
8/10/2022	Kennedy Capital Management Inc.	39,891	$0.21M	0.0%	-72.1%	0.069%
8/9/2022	Lazard Asset Management LLC	17,628	$93K	0.0%	+74.2%	0.030%
8/8/2022	Walleye Capital LLC	204,096	$1.08M	0.0%	-26.1%	0.353%
8/5/2022	Cowen AND Company LLC	1,500,000	$7.95M	0.8%	N/A	2.596%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	16,287	$86K	0.0%	N/A	0.028%
8/3/2022	Envestnet Asset Management Inc.	11,614	$62K	0.0%	N/A	0.020%
8/2/2022	Lynwood Capital Management Inc.	300,000	$1.59M	1.8%	N/A	0.519%
8/1/2022	Timelo Investment Management Inc.	926,801	$4.91M	4.5%	+111.0%	1.604%
7/25/2022	Allspring Global Investments Holdings LLC	22,520	$0.12M	0.0%	+23.1%	0.039%
7/25/2022	Silverarc Capital Management LLC	208,330	$1.10M	0.3%	N/A	0.361%
7/20/2022	Values First Advisors Inc.	18,140	$96K	0.1%	+13.8%	0.031%
7/18/2022	North Growth Management Ltd.	75,000	$0.40M	0.1%	N/A	0.130%
6/7/2022	Bank of America Corp DE	4,708	$31K	0.0%	-99.8%	0.008%
5/27/2022	Walleye Capital LLC	276,307	$1.81M	0.0%	N/A	0.478%
5/18/2022	BNP Paribas Arbitrage SA	286,928	$1.88M	0.0%	+162.6%	0.497%
5/18/2022	Golden State Equity Partners	23,043	$0.15M	0.1%	+29.5%	0.040%
5/17/2022	Walleye Capital LLC	276,307	$1.81M	0.0%	N/A	0.478%
5/17/2022	Walleye Trading LLC	34,934	$0.23M	0.0%	N/A	0.060%
5/17/2022	Jane Street Group LLC	23,822	$0.16M	0.0%	-46.3%	0.041%
5/17/2022	Alyeska Investment Group L.P.	1,164,103	$7.63M	0.1%	+73.7%	2.015%
5/17/2022	Quantbot Technologies LP	6,482	$42K	0.0%	N/A	0.011%
5/17/2022	Dynamic Technology Lab Private Ltd	30,245	$0.20M	0.0%	N/A	0.052%
5/17/2022	Eventide Asset Management LLC	5,380,200	$35.24M	0.6%	+90.8%	9.313%
5/17/2022	First Republic Investment Management Inc.	10,000	$66K	0.0%	N/A	0.017%
5/17/2022	Guggenheim Capital LLC	20,713	$0.14M	0.0%	N/A	0.036%
5/16/2022	California State Teachers Retirement System	42,397	$0.28M	0.0%	+34.6%	0.073%
5/16/2022	Goldman Sachs Group Inc.	520,436	$3.41M	0.0%	-79.3%	0.901%
5/16/2022	PDT Partners LLC	110,673	$0.73M	0.1%	+13.6%	0.192%
5/16/2022	Woodline Partners LP	2,216,062	$14.52M	0.2%	+76.1%	3.836%
5/16/2022	Wellington Management Group LLP	1,175,788	$7.70M	0.0%	-58.8%	2.035%
5/16/2022	State Street Corp	137,271	$0.90M	0.0%	+9.6%	0.238%
5/16/2022	Graham Capital Management L.P.	137,601	$0.90M	0.0%	N/A	0.238%
5/16/2022	Maven Securities LTD	1,010,127	$6.62M	0.2%	N/A	1.749%
5/16/2022	Invesco Ltd.	46,540	$0.31M	0.0%	N/A	0.081%
5/13/2022	Renaissance Technologies LLC	547,900	$3.59M	0.0%	+237.0%	0.948%
5/13/2022	Lazard Asset Management LLC	10,117	$66K	0.0%	N/A	0.018%
5/13/2022	Parkman Healthcare Partners LLC	119,286	$0.78M	0.2%	+186.6%	0.206%
5/13/2022	Ergoteles LLC	67,149	$0.44M	0.0%	N/A	0.116%
5/13/2022	Vanguard Group Inc.	413,278	$2.71M	0.0%	+76.8%	0.715%
5/12/2022	BlackRock Inc.	973,451	$6.38M	0.0%	+20.0%	1.685%
5/12/2022	CI Investments Inc.	159,050	$1.04M	0.0%	+96.8%	0.275%
5/12/2022	Bank of Montreal Can	24,872	$0.17M	0.0%	+19.8%	0.043%
5/11/2022	Picton Mahoney Asset Management	87,146	$0.57M	0.0%	-12.7%	0.151%
5/11/2022	Raymond James Financial Services Advisors Inc.	71,967	$0.47M	0.0%	+12.3%	0.125%
5/11/2022	Raymond James & Associates	169,485	$1.11M	0.0%	-25.8%	0.293%

Data available starting January 2016

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. It is also advancing a pipeline of preclinical product candidates and discovery-stage programs in oncology, including immuno-oncology agents and other therapeutic areas. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; and Exelixis, Inc. It also has licensing and research collaboration with LEO Pharma A/S to research, develop, and commercialize bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.

Today's Range

Now: $9.58

$9.51

$9.82

50 Day Range

MA: $8.05

$6.00

$10.04

52 Week Range

Now: $9.58

$4.11

$10.80

Volume

370,059 shs

Average Volume

880,076 shs

Market Capitalization

$603.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of Zymeworks?: Zymeworks' top insider investors include:
Ecor1 Capital, Llc (Major Shareholder)
Ali Tehrani (CEO)
Neil Josephson (Insider)
Neil A Klompas (CFO)
Kathryn O'driscoll (Insider)
James Priour (Insider)
Christopher Astle (CFO)
Neil A Klompas (COO)
Learn More about top insider investors at Zymeworks.
Who are the major institutional investors of Zymeworks?: Zymeworks' top institutional investors include:
Stephens Inc. AR — 0.09%
Allspring Global Investments Holdings LLC — 0.06%
Learn More about top institutional investors of Zymeworks stock.
Which major investors are selling Zymeworks stock?: During the last quarter, ZYME stock was sold by these institutional investors:
Allspring Global Investments Holdings LLC
During the previous year, company insiders that have sold Zymeworks company stock include:
Ecor1 Capital, Llc (Major Shareholder)
Ali Tehrani (CEO)
Neil Josephson (Insider)
Learn More investors selling Zymeworks stock.
Which major investors are buying Zymeworks stock?: Within the previous quarter, ZYME stock was purchased by institutional investors including:
Stephens Inc. AR
During the last year, these company insiders have bought Zymeworks stock:
Ecor1 Capital, Llc (Major Shareholder)
Ali Tehrani (CEO)
Learn More investors buying Zymeworks stock.